Acute hemodynamic effect of sildenafil in comparison with inhaled nitric oxide in patients receiving bosentan therapy for pulmonary arterial hypertension

被引：0
|
作者：
Galie, Nazzareno [1 ]
Michelakis, Evangelos [1 ]
Vachiery, Jean-Lue [1 ]
Vizza, Carmine Dario [1 ]
Meyer, F. J. [1 ]
Gruenig, Ekkehard [1 ]
机构：
[1] Univ Bologna, Bologna, Italy
来源：
CHEST | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
下载
收藏
页码：488S / 488S
页数：1
相关论文
共 50 条
  • [1] Comparison of intravenous sildenafil with inhaled nitric oxide for acute vasodilator testing in pulmonary arterial hypertension
    Kumar, Shine
    Memon, Danish
    Raj, Manu
    Sen, Amitabh C.
    Jayasankar, Jessin P.
    Leeladharan, Sreelakshmi P.
    Sudhakar, Abish
    Kumar, Raman K.
    PULMONARY CIRCULATION, 2022, 12 (04)
  • [2] Comparison of acute hemodynamic effects of inhaled nitric oxide and inhaled epoprostenol in patients with pulmonary hypertension
    Preston, Ioana R.
    Sagliani, Kristen D.
    Roberts, Kari E.
    Shah, Archan M.
    DeSouza, Shilpa A.
    Howard, William
    Brennan, John
    Hill, Nicholas S.
    PULMONARY CIRCULATION, 2013, 3 (01) : 68 - 73
  • [3] Comparison of Acute Hemodynamic effects of inhaled Nitric Oxide (iNo) and inhaled Epoprostenol (iEPO) in patients with Pulmonary Arterial Hypertension (PAH)
    Shah, A. M.
    Siddiqui, F.
    Preston, I. R.
    Brennan, J.
    Roberts, K.
    Howard, W.
    Hill, N. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [4] Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension - Comparison with inhaled nitric oxide
    Michelakis, E
    Tymchak, W
    Lien, D
    Webster, L
    Hashimoto, K
    Archer, S
    CIRCULATION, 2002, 105 (20) : 2398 - 2403
  • [5] Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension
    McLaughlin, Vallerie
    Channick, Richard N.
    Ghofrani, Hossein-Ardeschir
    Lemarie, Jean-Christophe
    Naeije, Robert
    Packer, Milton
    Souza, Rogerio
    Tapson, Victor F.
    Tolson, Jonathan
    Al Hiti, Hikmet
    Meyer, Gisela
    Hoeper, Marius M.
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (02) : 405 - 413
  • [6] Combination therapy with bosentan and sildenafil compared with bosentan alone in patients with pulmonary arterial hypertension
    Al-Sharif, Hassan
    Bshouty, Zoheir
    CHEST, 2006, 130 (04) : 255S - 256S
  • [7] Acute Effect of Sildenafil Is Maintained in Pulmonary Arterial Hypertension Patients Chronically Treated With Bosentan
    Hatano, Masaru
    Yao, Atsushi
    Kinugawa, Koichiro
    Hirata, Yasunobu
    Nagai, Ryozo
    INTERNATIONAL HEART JOURNAL, 2011, 52 (04) : 233 - 239
  • [8] Hemodynamic Effects of First-Line Bosentan and Sildenafil Combination Therapy for Pulmonary Arterial Hypertension
    Weatherald, Jason
    Helmersen, Doug
    Thakrar, Mitesh
    Hirani, Naushad
    CHEST, 2013, 144 (04)
  • [9] Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension
    Lepore, JJ
    Maroo, A
    Pereira, NL
    Ginns, LC
    Dec, GW
    Zapol, WM
    Bloch, KD
    Semigran, MJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (06): : 677 - +
  • [10] The addition of sildenafil to bosentan therapy in the treatment of pulmonary arterial hypertension
    Mathai, SC
    Fisher, MR
    Housten-Harris, T
    Girgis, RE
    Hassoun, PM
    CHEST, 2005, 128 (04) : 161S - 162S
12345